Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Lipids in Health and Disease|November 15, 2011
Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatinAlvaro Cerda, Fabiana D V Genvigir, Maria A V Willrich, et al.
Drug Metabolism and Drug Interactions|April 13, 2011
Tumor necrosis factor-α and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazoneSilvia T Himelfarb, Fernanda A Silva, Simone S Arazi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 2008
CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemiaMaria Alice V Willrich, Mario H Hirata, Fabiana D V Genvigir, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 1, 2008
Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individualsFabiana D V Genvigir, Sarah A Soares, Mario H Hirata, et al.
Clinical Endocrinology|December 28, 2017
Adiponectin concentration data improve the estimation of atherosclerotic risk in normal and in overweight subjectsAdriana Bertolami, José C de Lima-Júnior, Riobaldo M Cintra, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 19, 2013
Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patientsMaria Alice V Willrich, Alice C Rodrigues, Alvaro Cerda, et al.
Genetic Testing and Molecular Biomarkers|February 1, 2012
Differentiation of African components of ancestry to stratify groups in a case-control study of a Brazilian urban populationVivian N Silbiger, Mario H Hirata, Andre D Luchessi, et al.
International Journal of Molecular Sciences|October 22, 2011
Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin responseAlice C Rodrigues, Paula M S Perin, Sheila G Purim, et al.
Current Medical Research and Opinion|October 26, 2016
Statin-associated muscle symptoms: position paper from the Luso-Latin American ConsortiumAndrei C Sposito, José Rocha Faria Neto, Luiz Sergio F de Carvalho, et al.
Atherosclerosis|October 1, 2008
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) studyMaria C Izar, Tatiana Helfenstein, Silvia S Ihara, et al.
Pageof 3